BioSyent (CVE:RX) Stock Crosses Above 50-Day Moving Average – What’s Next?

BioSyent Inc. (CVE:RX) shares passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$14.36 and traded as high as C$15.50. BioSyent shares last traded at C$15.49, with a volume of 416 shares traded.

BioSyent Price Performance

The company has a current ratio of 1.89, a quick ratio of 6.91 and a debt-to-equity ratio of 11.66. The company has a market cap of C$175.53 million, a PE ratio of 19.76 and a beta of 1.00. The firm has a 50 day moving average of C$14.36 and a two-hundred day moving average of C$14.49.

Insider Activity at BioSyent

In other news, Director Seyed Ahmad Ashrafi sold 1,884 shares of the firm’s stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of C$14.65, for a total transaction of C$27,600.60. Following the completion of the transaction, the director directly owned 37,261 shares in the company, valued at C$545,873.65. This trade represents a 4.81% decrease in their ownership of the stock. Insiders sold 4,358 shares of company stock valued at $63,132 over the last 90 days. Corporate insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis.